Get Social

Submit your Twitter account related to Stage Ii Vaginal Cancer to be featured!


Submit your blog on Stage Ii Vaginal Cancer to be featured!


Submit your event on Stage Ii Vaginal Cancer to be featured!


Submit your video on Stage Ii Vaginal Cancer to be featured!


Submit your charity on Stage Ii Vaginal Cancer to be featured!

Stage Ii Vaginal Cancer: Disease Bioinformatics

Vaginal cancer is a very rare cancer that occurs in the cells that line the muscular tube that connects the uterus to the outer genitals, frequently called the birth canal. Increased risk for vaginal cancer occurs with increasing age, smoking, HIV infection, multiple sexual partners, early age of first intercourse, the presence of atypical cells in the vagina called vaginal intraepithelial neoplasia, and exposure to the drug diethylstilbestrol (DES). There are four different types of vaginal cancer that are differentiated based on where the cancer begins: vaginal squamous cell carcinoma, vaginal adenocarcinoma, vaginal melanoma, and vaginal sarcoma. Treatments for vaginal cancer include: removal of tumors and lesions, vaginectomy, pelvic exenteration, radiation therapy, chemotherapy and clinical trials. In stage II of vaginal cancer, the cancer has spread to the connective tissues next to the vagina but has not gone beyond this point--the pelvis (including rectum, bladder, large intestine, and reproductive organs), the lymph nodes, and distant sites have not been affected.

Stage Ii Vaginal Cancer Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Vaginal Cancer below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 16 products for the study of Stage Ii Vaginal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.

Western Blot: SLC17A5 Antibody [NBP2-20383] - Sample (30 ug of whole cell lysate) A: Jurkat 10% SDS PAGE gel, diluted at 1:1000.Immunocytochemistry/Immunofluorescence: SLC17A5 Antibody [NBP2-20383] - Sample: HepG2 cells were fixed in -20C 100% MeOH for 5 min. Green: SLC17A5 protein stained by SLC17A5 antibody diluted at 1:500. Blue: Hoechst 33343 staining.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC

Western Blot: RanGAP1 Antibody (1B4) [NBP2-02623] Analysis of extracts (35ug) from 9 different cell lines by using anti-RanGAP1 monoclonal antibody.Immunocytochemistry/Immunofluorescence: RanGAP1 Antibody (1B4) [NBP2-02623] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY RanGAP1.

Mouse Monoclonal
Species Human, Rat, Canine
Applications WB, Flow, ICC/IF

Related Genes

Stage Ii Vaginal Cancer has been researched against:

Related Pathways

Related PTMs

Alternate Names

Stage Ii Vaginal Cancer is also known as Figo Stage Ii Vaginal Carcinoma.